Spectrum of Viral Pathogens Identified in Children with Clinical Myocarditis (Pre-Coronavirus Disease-2019, 2000-2018): Etiologic Agent Versus Innocent Bystander - 22/02/22
, Duncan Mackie, BS 3, Andras Bratincsak, MD, PhD 4, John S. Bradley, MD 5, James C. Perry, MD, FHRS 1
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Abstract |
Objective |
To identify the etiologies of viral myocarditis in children in the pre-coronavirus disease 2019 era.
Study design |
This was a retrospective review of all patients (age <18 years) diagnosed with myocarditis and hospitalized at Rady Children's Hospital San Diego between 2000 and 2018.
Results |
Twenty-nine patients met inclusion criteria. Of 28 (97%) patients who underwent testing for viruses, polymerase chain reaction was used in 24 of 28 (86% of cases), and 16 of 24 (67%) detected a virus. Pathogens were rhinovirus (6), influenza A/B (4), respiratory syncytial virus (RSV) (3), coronavirus (3), parvovirus B19 (2), adenovirus (2), and coxsackie B5 virus, enterovirus, and parainfluenza virus type 2 in one case each. Six (21%) patients had no pathogen detected but imaging and other laboratory test results were compatible with myocarditis. Age 0-2 years was associated with RSV, influenza A/B, coronavirus, and enteroviruses (P < .001). Twenty-one patients (72%) experienced full clinical recovery. Three patients (10%) required venoarterial extracorporeal membrane oxygenation (VA-ECMO), and all 3 recovered. Three others (10%) required and underwent successful cardiac transplantation without complications. Two patients (7%) died 9-10 days after hospitalization (1 had RSV and 1 had influenza A/B). Two other patients presented with complete atrioventricular block; 1 case (rhinovirus) resolved spontaneously, and 1 (coronavirus) resolved after support with VA-ECMO. Age <2 years, female sex, lower ejection fraction at admission, and greater initial and peak levels of brain natriuretic peptide were significant predictors of critical outcomes (use of VA-ECMO, listing for cardiac transplantation, and death).
Conclusions |
Viral nucleic acid-based testing revealed a wider spectrum of viruses that could be associated with myocarditis in children than previously reported and traditionally anticipated. A predilection of certain pathogens in the very young patients was observed. Whether the observed range of viral agents reflects an undercurrent of change in viral etiology or viral detection methods is unclear, but the wider spectrum of viral pathogens found underscores the usefulness of polymerase chain reaction testing to explore possible viral etiologies of myocarditis in children.
Le texte complet de cet article est disponible en PDF.Keywords : viral myocarditis, fulminant myocarditis, extracorporeal membrane oxygenation, ECMO, children
Abbreviations : BNP, CAVB, cMRI, ECG, EF, EMB, ICU, PCR, RSV, VA-ECMO
Plan
| Supported by the National Institutes of Health, United States (NIH; TL1TR001443 [to D.M.]). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The authors declare no conflicts of interest. |
Vol 242
P. 18-24 - mars 2022 Retour au numéro
Article précédent
- Pediatrician Adherence to Guidelines for Diagnosis and Management of High Blood Pressure
- Corinna J. Rea, Tammy M. Brady, David G. Bundy, Moonseong Heo, Elissa Faro, Kimberly Giuliano, Beatrice Goilav, Peterkaye Kelly, Kelly Orringer, Beth A. Tarini, Katherine Twombley, Michael L. Rinke
- Effect of an Alternate Definition for a Clinically Significant Cardiopulmonary Event on Discharge
- Andrew C. Beckstrom, Grace Lin, Leah Ngoche, Sally Perla, Reese H. Clark, Michael Kamitsuka
Bienvenue sur EM-consulte, la référence des professionnels de santé.